Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-07-005882
Filing Date
2007-03-16
Accepted
2007-03-16 06:02:57
Documents
9
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K h44503e10vk.htm 10-K 720469
2 EIGHTH AMENDMENT TO CONSULTING AGREEMENT h44503exv10w2.htm EX-10.2 6715
3 SUBSIDIARIES OF THE REGISTRANT h44503exv21w1.htm EX-21.1 6880
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM h44503exv23w1.htm EX-23.1 3012
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER h44503exv31w1.htm EX-31.1 6985
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER h44503exv31w2.htm EX-31.2 6468
7 CERTIFICATION PURSUANT TO SECTION 906 h44503exv32w1.htm EX-32.1 2460
8 CERTIFICATION PURSUANT TO SECTION 906 h44503exv32w2.htm EX-32.2 2400
9 GRAPHIC h44503h4450301.gif GRAPHIC 13061
  Complete submission text file 0000950134-07-005882.txt   775081
Mailing Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081
Business Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081 7137968822
ENCYSIVE PHARMACEUTICALS INC (Filer) CIK: 0000887023 (see all company filings)

EIN.: 133532643 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20117 | Film No.: 07697943
SIC: 2834 Pharmaceutical Preparations